The BIO International Convention Enters its Final Day of “Breakthrough” Programming

Day four will feature the annual Scientific American WorldVIEW of the global biotechnology industry

SAN DIEGO--()--The 2017 BIO International Convention (BIO 2017), the world’s largest gathering of the biotechnology industry, entered the fourth and final day of compelling, immersive programming united under the theme of “Breakthrough.” Hosted by the Biotechnology Innovation Organization (BIO), BIO 2017 has been running this week at the San Diego Convention Center.

The final day of BIO 2017 will include annual Scientific American WorldVIEW of the global biotechnology industry and a special program session focused on San Diego veterans who have made the transition into the life sciences world.

Thursday, June 22 Highlights Include:

  • Business Development & Finance: Inside the Minds of the Next Generation of Life Science VCs
    Billions of dollars of investment capital flowing into emerging biotech startups, and there’s much at stake. This panel of young, tech savvy venture capitalists will share how they view opportunities, the gaps they see in today’s healthcare market, and the solutions they’re eager to fund.
    9:00 – 10:00 a.m. | Room 8, Upper Level
  • Digital Health: Digital Health’s Rocky Road: Business Plans that Work
    In this panel, digital health leaders will share the challenges and lessons learned from collaborating with pharmaceutical companies. They will address questions including: What will allow companies to succeed and thrive in this nascent industry? Will it be collaborations with pharma partners? Or mastering the health insurance system? Or pursuing self-insurance programs?
    10:15 – 11:15 a.m. | Room 6EF, Upper Level
  • Personalized Medicine & Diagnostics: The Whole Picture: Consideration of Personalized Medicine in Value Assessment Frameworks
    Value assessment frameworks are a relatively new concept in healthcare, designed to help providers and patients choose treatments and guide reimbursement decisions. It is not yet clear how these frameworks apply to personalized medicines. Biopharma leaders will examine the current challenges associated with value assessment frameworks, and how they can evolve to account for personalized therapies and diagnostics.
    10:15 – 11:15 a.m. | Room 6D, Upper Level
  • Digital Health: Detect, Predict, Prevent: Using Digital Technologies to Tackle Brain Disorders
    Join researchers from leading academic institutions, patient advocacy organizations and biopharma innovators who will discuss how data generated from smartphones and wearables can help predict and even prevent brain disorders, such as depression, multiple sclerosis and epilepsy. Panelists will address pressing questions such as: How can we ensure the quality of the data generated? How can the data gathered help identify endpoints for clinical studies? And most importantly, how can we best capture those breakthroughs that have the potential to improve patients’ lives?
    11:30 a.m. – 12:45 p.m. | Room 7A, Upper Level
  • Special Program: Veterans Career Roundtable: From Service to Life Science
    San Diego veterans will discuss how they made successful transitions from careers in service to careers in life science and what resources fellow veterans need to prepare for impactful and meaningful employment in the biotech industry. Learn about the many valuable resources that are locally available for vets and how to get the most out of the BIO Talent Connect event, immediately following.
    1:00 – 2:00 p.m. | Spotlight Theatre: Sails Pavilion
  • Super Session: The Scientific American WorldVIEW Super Session: Wrapping Up and Looking Forward
    Join Scientific American WorldVIEW and Nature Biotechnology for a discussion around the multiplicity of issues explored during the week's programs and get a snapshot of future trends. Key industry thought leaders will tackle the latest commercial, scientific and ethical issues facing innovation stakeholders today, and provide us with their views of the year ahead. Co-hosted by Scientific American and Nature Biotechnology, and moderated by Andrew Marshall, Chief Editor, Nature Biotechnology, this Super Session, now in its 9th year, will examine global life science innovation in unique and dynamic new ways.
    1:00 – 2:30 p.m. | Room 6A, Upper Level

Follow the 2017 Convention @BIOConvention, and join the conversation and @IAmBIOtech.

The BIO International Convention is the largest global event for the biotechnology industry and attracts the biggest names in biotech, offers key networking and partnering opportunities, and provides insights and inspiration on major trends affecting the industry. The Convention will highlight the latest trends and the newest opportunities for executives, investors, scientists, policy leaders, and media from around the world. Speakers at the sessions will share breakthroughs in medicine, diagnostics, the environment, energy production, business operations, financing, partnerships, policy issues and food and agriculture. Visit for the most up-to-date program and speaker information.

About BIO

BIO is the world's largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIOtechNOW is BIO's blog chronicling “innovations transforming our world” and the BIO Newsletter is the organization’s bi-weekly email newsletter. Subscribe to the BIO Newsletter.

Upcoming BIO Events

BIO World Congress
on Industrial Biotechnology
Montréal, Canada
July 23-26, 2017

BIO Patient and Health
Advocacy Summit
The Mayflower Hotel, Washington, DC
October 2-3, 2017

BIO Investor Forum
San Francisco
October 17-18, 2017


Biotechnology Innovation Organization (BIO)
Theresa Brady, 202-997-9034
Twitter: @IAmBiotech


Biotechnology Innovation Organization (BIO)
Theresa Brady, 202-997-9034
Twitter: @IAmBiotech